Correction: Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab
Cureus
.
2024 May 8;16(5):c172.
doi: 10.7759/cureus.c172.
eCollection 2024 May.
Authors
Naresh Gupta
1
2
,
Anupam Dutta
3
,
Bilal Ahmed
4
,
Cecil R Ross
5
,
Chandrakala S
6
,
Gerard Dolan
7
,
M J John
8
,
Nita Radhakrishnan
9
,
Sunita Aggarwal
10
,
Tulika Seth
11
,
Varun Kaul
12
,
Vijay Shah
13
Affiliations
1
Medicine and Surgery, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
2
Haematology & Haemophilia, Maulana Azad Medical College, Lok Nayak Hospital, New Delhi, IND.
3
General Medicine, Assam Medical College and Hospital, Dibrugarh, IND.
4
Pathology, Transfusion Medicine & Hemophilia, Government Medical College, Srinagar, IND.
5
Hematology, St. John's Medical College and Hospital, Bangalore, IND.
6
Clinical Haematology, King Edward Memorial Hospital, Mumbai, IND.
7
Haematology, St. Thomas' Haemophilia Comprehensive Care Centre, Bournemouth, GBR.
8
Clinical Hematology, Hemato-Oncology & Bone Marrow Transplant, Christian Medical College & Hospital, Ludhiana, IND.
9
Hematology and Oncology, Super Speciality Paediatric Hospital and Post Graduate Teaching Institute, Noida, IND.
10
Medicine, Maulana Azad Medical College, New Delhi, IND.
11
Hematology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.
12
Pediatrics, Guru Gobind Singh Medical College & Hospital, Faridkot, IND.
13
Pediatrics, Nirmal Hospital Pvt. Ltd., Surat, IND.
PMID:
38726357
PMCID:
PMC11081137
DOI:
10.7759/cureus.c172
Abstract
[This corrects the article DOI: 10.7759/cureus.58941.].
Copyright © 2024, Gupta et al.
Publication types
Published Erratum